NEXENTIS TECHNOLOGIES INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 29.22 million shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2025-03-31
- NEXENTIS TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 29.22M shares, a 6.17% increase from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 27.52M shares, a 81962.45% increase from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 33.53K shares, a 82.59% decline from fiscal 2021.
- NEXENTIS TECHNOLOGIES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 192.58K shares, a 6.91% decline from fiscal 2020.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | 29.22M shares 10-K · filed 2025-03-31 | |
| 2023-12-31 | 27.52M shares 10-K · filed 2025-03-31 | 27.52K shares 10-K · filed 2024-04-01 |
| 2022-12-31 | 33.53K shares 10-K · filed 2024-04-01 | 234.67K shares 10-K · filed 2023-03-27 |
| 2021-12-31 | 192.58K shares 10-K · filed 2023-03-27 | |
| 2020-12-31 | 206.86K shares 10-K · filed 2022-03-31 | |
| 2019-12-31 | 164.29K shares 10-K · filed 2021-03-29 | 1.15M shares 10-K · filed 2020-03-30 |
| 2018-12-31 | 416.67K shares 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |